CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop innovative carbon monoxide-releasing molecules activated by near-infrared light for personalized cancer treatment. It seeks to understand their interactions with living cells to enable non-invasive monitoring and treatment of tumors.
The capacity for imaging and treatment with a single assembly (“theranostic”) is a promising advance that seeks to further improve personalised cancer treatment.
This project aims to contribute a revolutionary step to this field through the development of near-infrared light-activated carbon monoxide-releasing molecules (NIRA-CORMs).
Carbon monoxide plays an important role in the regulation of stress response and in cell adaption to injury.
Moreover, pre-clinical trials applying this gas as a th…
HELMHOLTZ-ZENTRUM DRESDEN-ROSSENDORF EV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
